Search

everythinglearnresearchcommunity

for

Search:↓

Trichodynia found in 29% of TE or AGA patients, linked to psychological conditions.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Using lyopreserved umbilical tissue allograft may improve healing and reduce recurrence of pilonidal cysts.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Most women with weird scalp feelings had neck spine problems, and some got better with gabapentin treatment.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

Skin diseases, especially psoriasis, greatly affect people's quality of life, similar to chronic diseases.

A specific genetic change is linked to mental disorders, intellectual disability, and possibly autoimmune disease in a family.

Most adult chronic hair pullers are women who started in their early teens, often have other mental health issues, and may pull hair due to underlying psychiatric conditions.

Women with PCOS have more emotional and body image issues than healthy women.

Fluoxetine was not effective in treating hair-pulling disorder in the short term.

Most women with depression in the study had low vitamin D levels.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Managing diabetes can lead to eating disorders, and eating disorders can make diabetes harder to control.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

Gut flora changes could potentially indicate depression, but more research is needed.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

People with first-time vitiligo have lower levels of a certain brain protein compared to healthy individuals.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.